Israel Englander’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Israel Englander’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-49,478	Closed	-$122K	–	6704
2020 Q4	$122K	Sell	49,478 -76,370	-61%	-$150K	﹤0.01%	4987
2020 Q3	$257	Buy	+125,848	New	+$359K	﹤0.01%	3937
2019 Q3	–	Sell	-28,419	Closed	-$183K	–	4684
2019 Q2	$183K	Sell	28,419 -2,831	-9%	-$18.2K	﹤0.01%	3781
2019 Q1	$211K	Sell	31,250 -2,893	-8%	-$17.3K	﹤0.01%	3711
2018 Q4	$139K	Sell	34,143 -45,294	-57%	-$298K	﹤0.01%	3493
2018 Q3	$864K	Buy	+79,437	New	+$835K	﹤0.01%	2957

Other funds holding ETTX

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's ETTX Position: Q1 2021 in Review

Israel Englander sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2021, closing a stake of 49,478 shares — an estimated $122K sold.

Israel Englander first reported a position in ETTX in Q3 2018 and held it in 6 quarters. The position peaked at $864K in Q3 2018. 25 funds tracked by Wall St. Rank hold ETTX as of Q1 2021.

Israel Englander reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2021 after selling out during the quarter.
Israel Englander sold 49,478 Entasis Therapeutics Holdings Inc. shares in Q1 2021, an estimated $122K.
Israel Englander first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and held it in 6 quarters.
Israel Englander's Entasis Therapeutics Holdings Inc. position peaked at $864K in Q3 2018.
25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2021.

Based on Millennium Management's 13F filing for Q1 2021, filed 17 May 2021.